Maorex Tablets 0.5 mg (Rasagiline Mesylate)

Adult dose

This drug is administered orally to adults once daily as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy with a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy with levodopa: The recommended starting dose in patients taking levodopa is 0.5mg once daily. If well tolerated but the clinical response is inadequate, the dose may be increased to 1mg once daily. This drug may be taken with or without food.

This medication should not be administered to certain patients. First, patients allergic to the main ingredient or other components of this medication should not take it. Moreover, patients currently taking or who have recently discontinued other MAO inhibitors within the last two weeks should not use this medication. Patients taking specific medications such as pethidine, tramadol, or dextromethorphan should also not use this drug. This medication is not to be administered to patients with moderate to severe liver impairment. Various adverse reactions may occur during the use of this drug. Commonly reported side effects include headache, dizziness, depression, hallucinations, dermatitis, musculoskeletal pain, nausea, vomiting, constipation, and insomnia. Additionally, some patients may experience symptoms such as dyskinesia, orthostatic hypotension, accidental injury, or falling. If such symptoms occur, immediate consultation with a healthcare professional is necessary. This medication should be used with caution in patients with impaired liver function and should not be given to patients with moderate to severe liver dysfunction. No dosage adjustment is needed for patients with mild renal impairment, but sufficient information is lacking for patients with severe renal impairment. This drug may affect the ability to drive or operate machinery, so if drowsiness or sudden sleepiness occurs during treatment, patients should avoid hazardous activities. Caution is also needed as interactions may occur when taken with sedatives, central nervous system depressants, or certain antibiotics. Serious side effects may occur when this medication is used in conjunction with other MAO inhibitors, certain analgesics, or antidepressants, so it is essential to discuss this with a doctor. Particularly, it is safer to start this medication after discontinuing an antidepressant for a certain period. Women who are pregnant or breastfeeding should use this medication with caution, as there is insufficient information regarding its transmission to breast milk, and consultation with a professional is needed. Safety and efficacy in pediatric patients have not been established, so it is advisable not to use this drug in patients under 18 years of age. In the case of overdose, serious symptoms such as mania, hypertensive crisis, or serotonin syndrome may occur, so it is essential to avoid overdose and to immediately inform healthcare personnel for appropriate treatment if an overdose has occurred. This medication should be kept out of the reach of children and stored at temperatures between 1 and 25 degrees Celsius. Care should be taken not to transfer it to another container, as this may negatively affect quality.

• influenza
• skin cancer
• leukopenia
• allergy
• loss of appetite
• depression
• hallucinations
• headache
• cerebrovascular accident
• conjunctivitis

This medication should be stored in a tightly closed container, protected from air and moisture. The appropriate storage temperature is a cool place between 1 and 25 degrees Celsius.

Appearance

White round tablet

Package unit

30 tablets/PTP [10 tablets/PTP*3]